Henry Schein Expands and Extends Revolving Credit Facility
TipRanks (Tue, 22-Sep 6:58 AM ET)
Notable healthcare headlines for the week: Novo Nordisk, GE HealthCare, and Eli Lilly in focus
Seeking Alpha News (Sun, 20-Sep 9:05 AM ET)
Henry Schein to Participate in Upcoming Investor Conference in September
Business Wire (Tue, 8-Sep 6:30 AM ET)
Henry Schein Reports Strong Second Quarter 2026 Financial Results and Raises FY2026 Guidance
Business Wire (Tue, 4-Aug 6:00 AM ET)
Henry Schein Announces Leadership Transitions
Business Wire (Thu, 30-Jul 7:00 AM ET)
Business Wire (Tue, 21-Jul 6:30 AM ET)
PRNewswire (Tue, 30-Jun 9:01 AM ET)
Market Chameleon (Tue, 4-Nov 2:50 AM ET)
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
Henry Schein trades on the NASDAQ stock market under the symbol HSIC.
As of September 24, 2026, HSIC stock price climbed to $85.53 with 1,216,505 million shares trading.
HSIC has a beta of 0.22, meaning it tends to be less sensitive to market movements. HSIC has a correlation of 0.01 to the broad based SPY ETF.
HSIC has a market cap of $10.69 billion. This is considered a Large Cap stock.
Last quarter Henry Schein reported $3 billion in Revenue and $1.27 earnings per share. This beat revenue expectation by $86 million and exceeded earnings estimates by $.04.
In the last 3 years, HSIC traded as high as $92.18 and as low as $60.01.
The top ETF exchange traded funds that HSIC belongs to (by Net Assets): VTI, VOO, VB, RSP, VBR.
HSIC has outperformed the market in the last year with a return of +23.6%, while the SPY ETF gained +16.8%. In the last 3 month period, HSIC beat the market returning +6.8%, while SPY returned +4.8%. However, in the most recent 2 weeks HSIC has underperformed the stock market by returning -2.8%, while SPY returned +0.9%.
HSIC support price is $83.88 and resistance is $86.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HSIC shares will trade within this expected range on the day.
